Clinical Trial Detail

NCT ID NCT01528046
Title Metformin in Children With Relapsed or Refractory Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

Advanced Solid Tumor

Therapies

Metformin

Irinotecan + Temozolomide + Vincristine Sulfate

Age Groups: child

No variant requirements are available.